Home United States dc3 United States criminal in english pdf ‘Pharmo Bro’ Martin Shkreli Hit With $64.6 Million Fine And Lifetime Ban...

‘Pharmo Bro’ Martin Shkreli Hit With $64.6 Million Fine And Lifetime Ban From Pharmaceutical Industry

256
0
SHARE

Shkreli is still in prison after being convicted of securities fraud in 2017.
A federal judge ruled Friday morning that Martin Shkreli, a former hedge fund manager convicted of securities fraud in 2017, must pay $64.4 million in fines to states that filed an antitrust lawsuit over his dramatic increase to the price of Daraprim, a life-saving drug, in 2015. Shkreli came under public scrutiny in 2015 when his pharmaceutical company Turing acquired Daraprim and raised the price from $13.50 a tablet to $750. Daraprim treats toxoplasmosis, an infectious disease. In 2020, New York State Attorney General Letitia James filed a lawsuit accusing Shkreli of blocking competition from generic drug companies by preventing them from accessing Daraprim to conduct testing in line with Food and Drug Administration regulations. The suit also claims Shkreli used exclusive supply agreements to limit the market availability of the drug’s active ingredients.